Yang Rick insider trades
Yang Rick has filed 13 Form 4s with the SEC that we hold, for NEUE (Director, 10% owner), Korro Bio, Inc. (KRRO) (10% owner), MBX Biosciences, Inc. (MBX) (10% owner) and Savara Inc (SVRA) (10% owner), among 5 companies in all. Across all of them we count 5 purchases worth $27.3M and 3 sales worth $24.5K reported on Form 4. In the last 12 months: 2 purchases ($17.3M) and 0 sales ($0). The largest single trade was a purchase of 937,500 shares of SpyGlass Pharma, Inc. worth $15.0M, dated 2026-02-09. The first filing on our record is dated 2022-10-19 and the latest 2026-03-12.
NEUE
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-10-02 | S, sale reported on Form 4 | 900 | $6.1K | 2025-10-06 |
| 2025-10-02 | S, sale reported on Form 4 | 280 | $1.9K | 2025-10-06 |
| 2025-10-02 | S, sale reported on Form 4 | 2,455 | $16.6K | 2025-10-06 |
Korro Bio, Inc. (KRRO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-04-22 | P, purchase reported on Form 4 | 17,857 | $1,000.0K | 2024-04-24 |
| 2026-03-10 | P, purchase reported on Form 4 | 207,100 | $2.3M | 2026-03-12 |
MBX Biosciences, Inc. (MBX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-09-16 | P, purchase reported on Form 4 | 500,000 | $8.0M | 2024-09-17 |
Savara Inc (SVRA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-07-17 | P, purchase reported on Form 4 | 333,333 | $1,000.0K | 2023-07-19 |
SpyGlass Pharma, Inc. (SGP)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-02-09 | P, purchase reported on Form 4 | 937,500 | $15.0M | 2026-02-11 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1851328) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms